Follow-On Biologics : Intellectual Property and Innovation Issues.

Reviews expedited marketing approval, intellectual property, and innovation issues pertaining to follow-on biologics, also called biopharmaceuticals or biotechnology drugs.

Bibliographic Details
Corporate Authors:	Library of Congress. Congressional Research Service, ProQuest (Firm)
Format:	eBook
Language:	English
Published:	[Place of publication not identified] : [publisher not identified], 2009.
Series:	U.S. Congressional Research.
Subjects:	Biotechnology. Marketing. Technological innovations. Electronic books.
Online Access:	Connect to the full text of this electronic book

Description
Summary:	Reviews expedited marketing approval, intellectual property, and innovation issues pertaining to follow-on biologics, also called biopharmaceuticals or biotechnology drugs.
Item Description:	Record is based on bibliographic data in ProQuest U.S. Congressional Research Digital Collection (last viewed Dec. 2010). Reuse except for individual research requires license from ProQuest, LLC. CRS Report. Electronic resource.
Physical Description:	1 online resource.